C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/27/2011	US8084257 differentiating post-mitotic (or post meiotic) eukaryotic and prokaryotic daughter cells due to differences in the cells' DNA, RNA, chromatin associated proteins, or other distinguishable cellular features; Labeling, tagging, or marking; dramatically improve visualization of cellular morphology
12/27/2011	US8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084255 Stem cells treated by in vitro fucosylation and methods of use
12/27/2011	US8084254 Human blood brain barrier model
12/27/2011	US8084253 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084252 Recombinant cell clones having increased stability and methods of making and using the same
12/27/2011	US8084251 Recombinant cell clones having increased stability and methods of making and using the same
12/27/2011	US8084236 increasing engraftment potential of a cell, treating or alleviating a symptom of an immune disorder, tissue injury or cancer by administering to a subject, e.g. human a composition comprising the cells; CD34 and CD44
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody
12/27/2011	US8084229 GDEP enhancer element and use thereof to confer retinal specific gene expression
12/27/2011	US8084228 Nogo-B receptor antagonists
12/27/2011	US8084213 Selection
12/27/2011	US8084048 Vascularization enhanced graft constructs
12/27/2011	US8084033 Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment
12/27/2011	US8084028 Antibodies to VLA-1
12/27/2011	US8084023 Maintenance and propagation of mesenchymal stem cells
12/27/2011	US8084020 Use of anti-CD1 antibodies for the modulation of immune responses
12/27/2011	US8084017 In situ genetic engineering; generating image
12/22/2011	WO2011160128A2 Cardiomyocyte medium with dialyzed serum
12/22/2011	WO2011160066A1 Production of insulin producing cells
12/22/2011	WO2011160063A2 Methods and materials for assessing loss of heterozygosity
12/22/2011	WO2011160055A2 Hair follicle neogenesis
12/22/2011	WO2011160045A1 Isotopic labeling for the measurement of global protein levels and turnover in vivo
12/22/2011	WO2011160012A1 Tissue culture media containing trimethylamine n-oxide
12/22/2011	WO2011159938A2 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	WO2011159866A2 Bone filler material
12/22/2011	WO2011159797A2 A compendium of ready-built stem cell models for interrogation of biological response
12/22/2011	WO2011159779A2 Percutaneously deliverable valves
12/22/2011	WO2011159758A2 Long lasting drug formulations
12/22/2011	WO2011159726A2 Reprogramming of cells to a new fate
12/22/2011	WO2011159709A2 Photobioreactor system
12/22/2011	WO2011159692A1 Improved methods for producing induced pluripotent stem cells
12/22/2011	WO2011159684A2 Generation of induced pluripotent stem cells from small volumes of peripheral blood
12/22/2011	WO2011159572A2 Human blood-brain endothelial cells derived from pluripotent stem cells and blood-brain barrier model thereof
12/22/2011	WO2011159359A2 Serum-free chemically defined cell culture medium
12/22/2011	WO2011159075A2 Method for the differentiation of adult stem cells into neural progenitor cells using two-dimensional culture, and pharmaceutical composition for the treatment of diseases connected to neural damage using the neural progenitor cells
12/22/2011	WO2011159050A2 Method for differentiating human neural progenitor cells into dopaminergic neurons, and medium for differentiation thereof
12/22/2011	WO2011158973A1 Novel antifibrin antibody
12/22/2011	WO2011158967A1 Method for efficiently establishing induced pluripotent stem cell
12/22/2011	WO2011158960A1 Method for selecting human induced pluripotent stem cells
12/22/2011	WO2011158852A1 Process for production of induced pluripotent stem cell
12/22/2011	WO2011158845A1 Process for production of induced pluripotent stem cell, and induced pluripotent stem cell produced by the process
12/22/2011	WO2011158806A1 Process for production of hematopoietic stem cell
12/22/2011	WO2011158125A2 Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
12/22/2011	WO2011158025A1 In vitro bone model and distraction device
12/22/2011	WO2011157447A2 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	WO2011157057A1 Methods for complex tissue engineering
12/22/2011	WO2011157029A1 Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
12/22/2011	WO2011133878A3 Compositions and methods for selectively producing sirna
12/22/2011	WO2011133288A9 Microrna induction of pluripotential stem cells and uses thereof
12/22/2011	WO2011127398A3 In vitro cellular bioassay for neurotoxicity testing
12/22/2011	WO2011097330A3 Engineered biological nerve graft fabrication and application thereof
12/22/2011	WO2011079017A9 Differentiation of human embryonic stem cells
12/22/2011	WO2011072276A3 Cell lines from the black witch moth ascalapha odorata
12/22/2011	US20110314575 Plasmodium Vaccines, Antigens, Compositions and Methods
12/22/2011	US20110314572 Cotton plant with seed-specific reduction in gossypol
12/22/2011	US20110314571 Method to trigger rna interference
12/22/2011	US20110314570 Drought tolerant plants and related constructs and methods involving genes encoding zinc-finger (c3hc4-type ring finger) family polypeptides
12/22/2011	US20110314569 Combination of Two Genetic Elements for Controlling the Floral Development of a Dicotyledonous Plant, and Use in Detection and Selection Methods
12/22/2011	US20110314568 Soybean Cultivar S090069
12/22/2011	US20110314567 Soybean Cultivar S090057
12/22/2011	US20110314566 Soybean Cultivar S090086
12/22/2011	US20110314565 Method for Isolating Cell-Type Specific mRNAS
12/22/2011	US20110314564 Enzymes and methods for hydrolysing phenylureas, carbamates and organophosphates
12/22/2011	US20110313542 Engineered biological nerve graft, fabrication and application thereof
12/22/2011	US20110313541 Methods for generating cartilage tissue
12/22/2011	US20110313540 in or relating to growing cells
12/22/2011	US20110313229 Therapy Targeting Cancer Stem Cells
12/22/2011	US20110313139 Method for polyclonal immunoglobulin g production by human b cells
12/22/2011	US20110313135 Recombinant Monovalent Antibodies
12/22/2011	US20110313045 Histone deacetylases, and uses related thereto
12/22/2011	US20110313031 Olioodeoxynucleotide and its use to induce an immune response
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313028 Suppressor of ap-1
12/22/2011	US20110313025 Methods and compositions involving mirna and mirna inhibitor molecules
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313019 Oligomeric compounds and methods
12/22/2011	US20110313017 Snalp formulations containing polyoxazoline-dialkyloxypropyl conjugates
12/22/2011	US20110313013 Triple reuptake inhibitors and methods of their use
12/22/2011	US20110313003 Gpr120 receptor agonists and uses thereof
12/22/2011	US20110312984 Stat3 inhibitors
12/22/2011	US20110312943 Aurora kinase inhibitors for inhibiting mitotic progression
12/22/2011	US20110312922 EDTA Resistant S100A12 Complexes (ERAC)
12/22/2011	US20110312919 Inhibitors of tyrosine kinase receptor dimerization
12/22/2011	US20110312904 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
12/22/2011	US20110312899 HDL Particles for Delivery of Nucleic Acids
12/22/2011	US20110312897 Cathepsin l proteolytically processes histone h3 during mouse embryonic stem cell differentiation
12/22/2011	US20110312893 Method for isolating neural cells with tenascin-r compounds
12/22/2011	US20110312892 Anxiolytic compositions containing alpha s1-casein-derived peptides
12/22/2011	US20110312891 Enamel matrix derivative fraction c
12/22/2011	US20110312881 Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
12/22/2011	US20110312543 Expression Vectors Based on Modified Ribosomal Protein Promoters and Uses Thereof in Post-Transcriptional Assessment
12/22/2011	US20110312533 CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312093 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
12/22/2011	US20110312092 Dual-terminal amide hydrogelling agent
12/22/2011	US20110312091 Pluripotent stem cells, method for preparation thereof and uses thereof
12/22/2011	US20110312090 Cardiomyocyte medium with dialyzed serum
12/22/2011	US20110312089 Process for cultivating cells
12/22/2011	US20110312088 Cd19 binding agents and uses thereof

1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 1827